
AnaptysBio (NASDAQ:ANAB) brought in sales totaling $1.01 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 388.12%, resulting in a loss of $32.54 million. In Q3, AnaptysBio brought in $20.89 million in sales but lost $6.67 million in earnings.